WS

William R. Sellers

DI Dana-Farber Cancer Institute: 13 patents #47 of 1,343Top 4%
The General Hospital: 8 patents #184 of 3,021Top 7%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
UP University of Pennsylvania: 3 patents #522 of 2,719Top 20%
WR Whitehead Institute For Biomedical Research: 2 patents #113 of 438Top 30%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
📍 Sharon, MA: #60 of 848 inventorsTop 8%
🗺 Massachusetts: #6,946 of 88,656 inventorsTop 8%
Overall (All Time): #268,321 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
12006555 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2024-06-11
11578130 Regulatable chimeric antigen receptor Jennifer Brogdon, Boris Engels, David Glass, Brian Granda, John Hastewell +9 more 2023-02-14
11530413 Compositions and methods to treat cancer Eric Billy, Antoine DE WECK, Javad GOLJI, Gregory HOFFMAN, Francesco Hofmann +6 more 2022-12-20
10669589 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2020-06-02
10357514 Treatment of cancer using anti-CD19 Chimeric Antigen Receptor Carl H. June, David L. Porter, Marcela Maus, Mariusz A. Wasik, Saar Gill +11 more 2019-07-23
10287354 Regulatable chimeric antigen receptor Jennifer Brogdon, Boris Engels, David Glass, Brian Granda, John Hastewell +9 more 2019-05-14
10000815 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2018-06-19
9035036 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2015-05-19
8465916 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnston, Thomas J. Lynch +4 more 2013-06-18
8105769 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnston, Thomas J. Lynch +4 more 2012-01-31
7981609 Methods for identifying and using SNP panels Mark A. Rubin, Francesca Demichelis, Levi A. Garraway 2011-07-19
7964349 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnston, Thomas J. Lynch +4 more 2011-06-21
7501248 Prostate cancer diagnosis and outcome prediction by expression analysis Todd Golub, Phillip Febbo, Kenneth Ross 2009-03-10
7294468 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2007-11-13
6949342 Prostate cancer diagnosis and outcome prediction by expression analysis Todd Golub, Phillip Febbo, Kenneth Ross 2005-09-27
5981723 Retinoblastoma-associated protein 1 CDNA William G. Kaelin, Jr., Erik Flemington, James Decaprio, David Livingston 1999-11-09
5759803 Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA William G. Kaelin, Jr., Erik Flemington, David Livingston 1998-06-02